Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00991419 · ClinicalTrials.gov registry record · Phase 2
To Compare Positron Emission Tomography (PET) Measurements of Fibrillar Amyloid Burden
A Phase 2 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 2
- Development phase
- 25
- Enrollment target
NCT00991419 is a Phase 2 study that has completed, run by AstraZeneca. The registered enrollment target is 25 participants.
The verdict
NCT00991419, a Phase 2 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to compare PET measurements of fibrillar amyloid burden using \[18F\]AZD4694.
Interventions
- DRUG [18F]AZD4694
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00991419
The ClinicalTrials.gov registry entry for NCT00991419 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [18F]AZD4694 is the first listed.
NCT00991419 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00991419 about?
NCT00991419 is a clinical study titled "To Compare Positron Emission Tomography (PET) Measurements of Fibrillar Amyloid Burden". The purpose of this study is to compare PET measurements of fibrillar amyloid burden using \[18F\]AZD4694.
What is the current status of trial NCT00991419?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 2010-02. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00991419?
The interventions under investigation include: [18F]AZD4694 (DRUG).
Who is sponsoring clinical trial NCT00991419?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.